By Bill Berkrot (Reuters) – The U.S. Food and Drug Administration said on Thursday it approved an Eli Lilly and Co drug to treat advanced breast cancer that has progressed following prior treatment. The drug, abemaciclib, which will be sold under the brand name Verzenio, will carry a list price before any discounts or rebates […]
Read More
By Toni Clarke (Reuters) – PTC Therapeutics Inc’s experimental drug to treat Duchenne muscular dystrophy, a devastating degenerative disease that mostly affects young boys, may work but the company will need to do more work to prove it, an advisory panel to the U.S. Food and Drug Administration concluded on Thursday. The panel’s vote reduces […]
Read More
By Leah Schnurr OTTAWA (Reuters) – Canada outlined its vision for its cultural and entertainment industries on Thursday, promising more money to foster Canadian content at home and abroad and striking a deal in which streaming service Netflix would invest C$500 million to create programming in the country. The announcement was part of a sweeping […]
Read More
By Nate Raymond (Reuters) – Washington state on Thursday sued OxyContin maker Purdue Pharma LP, becoming the latest state or local government to file a lawsuit seeking to hold pharmaceutical companies accountable for a national opioid addiction epidemic. The city of Seattle also filed a separate lawsuit against Purdue as well as units of Teva […]
Read More
WASHINGTON (Reuters) – Two U.S. senators from both parties are close to finalizing a bipartisan deal to shore up the health insurance exchanges created under Obamacare, the chamber’s top Democrat said on Thursday. The move, which Senate Democratic Leader Chuck Schumer said was “on the verge” of completion, would stabilize the market for individuals who […]
Read More By Lisa Rapaport (Reuters Health) – Nearly two-thirds of children and teens with terminal cancer receive intense care at the end of life, often in hospitals and intensive care units, a U.S. study suggests. Certain patients, including kids under age 5 and teens aged 15 to 21 as well as ethnic minorities and patients with […]
Read More
By Diane Bartz WASHINGTON (Reuters) – Abbott Laboratories has won U.S. antitrust approval to buy Alere Inc on condition that it sell two point-of-care medical testing businesses, the Federal Trade Commission said on Thursday. Canada also announced on Thursday that it had approved the proposed transaction on similar terms. Alere’s shares were up 3.5 percent […]
Read More
By Julie Steenhuysen CHICAGO (Reuters) – A single genetic change that occurred in 2013 may explain how Zika acquired the ability to attack fetal nerve cells, causing a severe birth defect in babies whose mothers were infected while pregnant, Chinese and U.S. researchers reported on Thursday. Scientists have posited many theories about why Zika, a […]
Read More By Carolyn Crist (Reuters Health) – YouTube videos that depict alcohol brands favored by youth draw millions of views, making them a form of promotion that could encourage underage drinkers, according to a U.S. study. The videos often resemble traditional ads but may escape public health notice or parental controls, the study authors write in […]
Read More
By Jill Serjeant LOS ANGELES (Reuters) – Television comedy “Will & Grace” returns on Thursday with big shoes to fill: its own. Former U.S. Vice President Joe Biden said in 2012 that the 1990s series about a gay lawyer living with his straight female friend “probably did more to educate the American public (about gay […]
Read More
Facebook chief Mark Zuckerberg fired back at US President Donald Trump on Wednesday after he accused the leading social network of being “always anti-Trump.” Zuckerberg rejected the notion, countering that Facebook is working to ensure “free and fair elections” with an online platform that does not favor one side over another. Zuckerberg’s post at Facebook […]
Read More
The Senate Intelligence Committee has asked top tech companies Google, Facebook and Twitter to testify about Russian interference in US politics, a Senate aide confirmed Wednesday. The three internet and online social media giants are expected to appear on November 1 in an open hearing on the rising evidence that they were covertly manipulated in […]
Read More
